38 Current news of Roche

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Roche acquires Stratos Genomics

Further develop DNA based sequencing for diagnostic use

25-May-2020

Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX™). The Roche nanopore sequencer, ...

more

image description
Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization

Test results in three and half hours

13-Mar-2020

Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal and oropharyngeal swab samples ...

more

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

15-Apr-2015

Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood. CAPP ...

more

Roche acquires Signature Diagnostics

11-Feb-2015

Roche announced the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are ...

more

Roche acquires Bina Technologies and enters the genomic informatics market

22-Dec-2014

Roche announced the acquisition of Bina Technologies, Inc. (Bina), a privately held company based in Redwood City, California, USA. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data. "The acquisition of Bina is a significant step ...

more

Evotec receives first milestone in Roche biomarker collaboration

25-Apr-2014

Evotec AG announced the successful achievement of a milestone in its biomarker alliance with Roche. The milestone was achieved on the decision by Roche to use a response prediction marker, identified using Evotec's Proteome Profiling platform, in an extended phase I oncology trial. This is the ...

more

Roche and Molecular Partners enter into alliance

Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology

05-Dec-2013

Roche and Molecular Partners AG announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners’ DARPin® biologics conjugated to toxic agents developed at Roche for the ...

more

FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer

21-Apr-2011

Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent ...

more

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology

02-Jul-2010

Roche and IBM announced an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM’s recently published “DNA Transistor” technology, the collaboration will take advantage of IBM’s leadership in ...

more

caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche

30-Jun-2010

caprotec bioanalytics GmbH announced that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the binding ...

more

Page 1 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE